Patent details

EP1714960 Title: NOVEL THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS) OR DISEASE ATTRIBUTABLE TO ALS

Basic Information

Publication number:
EP1714960
PCT Application Number:
JP2005001932
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP057099848
PCT Publication Number:
WO2005075434
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS) OR DISEASE ATTRIBUTABLE TO ALS
French Title of Invention:
NOUVEL AGENT THERAPEUTIQUE POUR SCLEROSE LATERALE AMYOTROPHIQUE (SLA) OU MALADIE IMPUTABLE A LA SLA
German Title of Invention:
NEUES THERAPEUTISCHES MITTEL GEGEN AMYOTROPHISCHE LATERALSKLEROSE (ALS) ODER EINER ALS ZUSCHREIBBAREN KRANKHEIT
SPC Number:

Dates

Filing date:
09/02/2005
Grant date:
28/03/2018
EP Publication Date:
25/10/2006
PCT Publication Date:
18/08/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/03/2018
EP B1 Publication Date:
28/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/02/2019
Expiration date:
09/02/2025
Renunciation date:
Revocation date:
17/05/2020
Annulment date:

Owner

From:
21/03/2018
 
 

Name:
Mitsubishi Tanabe Pharma Corporation
Address:
2-10, Dosho-machi 3-chome Chuo-ku, Osaka-shi Osaka 541-8505, Japan (JP)

Inventor

1

Name:
YOSHINO, Hiide
Address:
Japan (JP)

2

Name:
YONEOKA, Takamoto, MITSUBISHI PHARMA CORPORATION
Address:
Japan (JP)

Priority

1

Priority Number:
2004032421
Priority Date:
09/02/2004
Priority Country:
Japan (JP)

2

Priority Number:
2004032420
Priority Date:
09/02/2004
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/4152; A61P 21/00; C07D 231/22;

Publication

European Patent Bulletin

1

Issue number:
201813
Publication date:
28/03/2018
Description:
Grant (B1)

2

Issue number:
201905
Publication date:
30/01/2019
Description:
Opposition procedure started

3

Issue number:
202039
Publication date:
23/09/2020
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages